Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.

Alakhova DY, Zhao Y, Li S, Kabanov AV

Open source

DOI
10.1371/journal.pone.0072238
Published
2013
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0072238,
  title = {Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.},
  author = {Alakhova DY and Zhao Y and Li S and Kabanov AV},
  year = {2013},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0072238},
  url = {https://doi.org/10.1371/journal.pone.0072238}
}

RIS

TY  - JOUR
TI  - Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.
AU  - Alakhova DY
AU  - Zhao Y
AU  - Li S
AU  - Kabanov AV
PY  - 2013
JO  - PloS one
DO  - 10.1371/journal.pone.0072238
UR  - https://doi.org/10.1371/journal.pone.0072238
ER  - 

APA

DY, A., Y, Z., S, L., & AV, K. (2013). Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.. PloS one. https://doi.org/10.1371/journal.pone.0072238

Source records